BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36284630)

  • 1. The Critical Gene Screening to Prevent Chromophobe Cell Renal Carcinoma Metastasis through TCGA and WGCNA.
    Yan C; Yang Y; Tang Y; Zheng X; Xu B
    J Oncol; 2022; 2022():2909095. PubMed ID: 36284630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
    Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L
    Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis.
    Yin X; Wang J; Zhang J
    Cancer Cell Int; 2018; 18():206. PubMed ID: 30564062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking enhanced the expression of c-kit in chromophobe renal cell carcinoma.
    Jiang J; Yang L; Chen M; Xiao F; Zeng Y; Zhu H; Li Y; Liu L
    Tob Induc Dis; 2023; 21():126. PubMed ID: 37808589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of
    Wang S; Yu ZH; Chai KQ
    Oncol Lett; 2019 Aug; 18(2):1767-1774. PubMed ID: 31423244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-2-Heremans-Schmid-glycoprotein (AHSG) a potential biomarker associated with prognosis of chromophobe renal cell carcinoma: The PROPOLIS study.
    Li X; Ma C
    Health Sci Rep; 2022 Nov; 5(6):e878. PubMed ID: 36262809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma.
    Lu Y; Luo G; Zhu S; Wang X; Chen Y; Dong Z; Wang S; Ma J; Deng H; Wu D; Dong J
    Clin Proteomics; 2020; 17():7. PubMed ID: 32127786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weighted Gene Coexpression Network Analysis to Construct Competitive Endogenous RNA Network in Chromogenic Renal Cell Carcinoma.
    Chen YB; Gao L; Zhang JD; Guo J; You PH; Tang LY; Liu YW
    Biomed Res Int; 2021; 2021():5589101. PubMed ID: 34222474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients.
    Ohashi R; Angori S; Batavia AA; Rupp NJ; Ajioka Y; Schraml P; Moch H
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32079343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype.
    Ohashi R; Schraml P; Angori S; Batavia AA; Rupp NJ; Ohe C; Otsuki Y; Kawasaki T; Kobayashi H; Kobayashi K; Miyazaki T; Shibuya H; Usuda H; Umezu H; Fujishima F; Furusato B; Osakabe M; Sugai T; Kuroda N; Tsuzuki T; Nagashima Y; Ajioka Y; Moch H
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.
    Li L; Chen X; Hao L; Chen Q; Liu H; Zhou Q
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32662515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.
    Hu D; Meng N; Lou X; Li Z; Teng Y; Tu B; Zou Y; Wang F
    Int J Gen Med; 2021; 14():3593-3609. PubMed ID: 34295182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and Molecular Characteristics of Macroscopically Yellowish-Colored Chromophobe Renal Cell Carcinoma Compared to Non-Yellowish-Colored Chromophobe Renal Cell Carcinoma.
    Kojima F; Matsuzaki I; Kuroda N; Mikasa Y; Musangile FY; Iwamoto R; Takahashi Y; Matsubara A; Kohjimoto Y; Hara I; Murata SI
    Clin Pathol; 2021; 14():2632010X211064821. PubMed ID: 34927071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
    Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
    Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.
    Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J
    Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
    An J; Park CK; Kim M; Joo JW; Cho NH
    Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.